127 related articles for article (PubMed ID: 21457553)
1. A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival.
Batra J; Nagle CM; O'Mara T; Higgins M; Dong Y; Tan OL; Lose F; Skeie LM; Srinivasan S; Bolton KL; Song H; Ramus SJ; Gayther SA; Pharoah PD; Kedda MA; Spurdle AB; Clements JA
BMC Cancer; 2011 Apr; 11():119. PubMed ID: 21457553
[TBL] [Abstract][Full Text] [Related]
2. Association between Prostinogen (KLK15) genetic variants and prostate cancer risk and aggressiveness in Australia and a meta-analysis of GWAS data.
Batra J; Lose F; O'Mara T; Marquart L; Stephens C; Alexander K; Srinivasan S; Eeles RA; Easton DF; Al Olama AA; Kote-Jarai Z; Guy M; Muir K; Lophatananon A; Rahman AA; Neal DE; Hamdy FC; Donovan JL; Chambers S; Gardiner RA; Aitken J; Yaxley J; Kedda MA; Clements JA; Spurdle AB
PLoS One; 2011; 6(11):e26527. PubMed ID: 22132073
[TBL] [Abstract][Full Text] [Related]
3. Kallikrein-related peptidase 10 (KLK10) expression and single nucleotide polymorphisms in ovarian cancer survival.
Batra J; Tan OL; O'Mara T; Zammit R; Nagle CM; Clements JA; Kedda MA; Spurdle AB
Int J Gynecol Cancer; 2010 May; 20(4):529-36. PubMed ID: 20686372
[TBL] [Abstract][Full Text] [Related]
4. Kallikrein-related peptidase 3 (KLK3/PSA) single nucleotide polymorphisms and ovarian cancer survival.
O'Mara TA; Nagle CM; Batra J; Kedda MA; Clements JA; Spurdle AB
Twin Res Hum Genet; 2011 Aug; 14(4):323-7. PubMed ID: 21787114
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of the human kallikrein gene 15 expression in ovarian cancer.
Yousef GM; Scorilas A; Katsaros D; Fracchioli S; Iskander L; Borgono C; Rigault de la Longrais IA; Puopolo M; Massobrio M; Diamandis EP
J Clin Oncol; 2003 Aug; 21(16):3119-26. PubMed ID: 12915603
[TBL] [Abstract][Full Text] [Related]
6. Identification of six novel alternative transcripts of the human kallikrein-related peptidase 15 (KLK15), using 3'RACE and high-throughput sequencing.
Adamopoulos PG; Koukouzeli FΕ; Kontos CK; Scorilas A
Gene; 2020 Jul; 749():144708. PubMed ID: 32334022
[TBL] [Abstract][Full Text] [Related]
7. The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer.
Yousef GM; Scorilas A; Magklara A; Memari N; Ponzone R; Sismondi P; Biglia N; Abd Ellatif M; Diamandis EP
Br J Cancer; 2002 Nov; 87(11):1294-300. PubMed ID: 12439720
[TBL] [Abstract][Full Text] [Related]
8. Quantified KLK15 gene expression levels discriminate prostate cancer from benign tumors and constitute a novel independent predictor of disease progression.
Mavridis K; Stravodimos K; Scorilas A
Prostate; 2013 Aug; 73(11):1191-201. PubMed ID: 23620432
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer.
Yousef GM; Scorilas A; Jung K; Ashworth LK; Diamandis EP
J Biol Chem; 2001 Jan; 276(1):53-61. PubMed ID: 11010966
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor gene polymorphisms and ovarian cancer survival.
Lose F; Nagle CM; O'Mara T; Batra J; Bolton KL; Song H; Ramus SJ; Gentry-Maharaj A; Menon U; Gayther SA; Pharoah PD; Kedda MA; Spurdle AB
Gynecol Oncol; 2010 Dec; 119(3):479-83. PubMed ID: 20832104
[TBL] [Abstract][Full Text] [Related]
11. Expression profile of human tissue kallikrein 15 provides preliminary insights into its roles in the prostate and testis.
Filippou PS; Ren AH; Soosaipillai A; Papaioannou MD; Korbakis D; Safar R; Diamandis EP; Conner JR
Clin Biochem; 2018 Sep; 59():78-85. PubMed ID: 29958881
[TBL] [Abstract][Full Text] [Related]
12. Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome.
Charbonneau B; Moysich KB; Kalli KR; Oberg AL; Vierkant RA; Fogarty ZC; Block MS; Maurer MJ; Goergen KM; Fridley BL; Cunningham JM; Rider DN; Preston C; Hartmann LC; Lawrenson K; Wang C; Tyrer J; Song H; deFazio A; Johnatty SE; Doherty JA; Phelan CM; Sellers TA; Ramirez SM; Vitonis AF; Terry KL; Van Den Berg D; Pike MC; Wu AH; Berchuck A; Gentry-Maharaj A; Ramus SJ; Diergaarde B; Shen H; Jensen A; Menkiszak J; Cybulski C; Lubiłski J; Ziogas A; Rothstein JH; McGuire V; Sieh W; Lester J; Walsh C; Vergote I; Lambrechts S; Despierre E; Garcia-Closas M; Yang H; Brinton LA; Spiewankiewicz B; Rzepecka IK; Dansonka-Mieszkowska A; Seibold P; Rudolph A; Paddock LE; Orlow I; Lundvall L; Olson SH; Hogdall CK; Schwaab I; du Bois A; Harter P; Flanagan JM; Brown R; Paul J; Ekici AB; Beckmann MW; Hein A; Eccles D; Lurie G; Hays LE; Bean YT; Pejovic T; Goodman MT; Campbell I; Fasching PA; Konecny G; Kaye SB; Heitz F; Hogdall E; Bandera EV; Chang-Claude J; Kupryjanczyk J; Wentzensen N; Lambrechts D; Karlan BY; Whittemore AS; Culver HA; Gronwald J; Levine DA; Kjaer SK; Menon U; Schildkraut JM; Pearce CL; Cramer DW; Rossing MA; Chenevix-Trench G; ; ; Pharoah PD; Gayther SA; Ness RB; Odunsi K; Sucheston LE; Knutson KL; Goode EL
Cancer Immunol Res; 2014 Apr; 2(4):332-40. PubMed ID: 24764580
[TBL] [Abstract][Full Text] [Related]
13. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
[TBL] [Abstract][Full Text] [Related]
14. Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set.
Beesley J; Jordan SJ; Spurdle AB; Song H; Ramus SJ; Kjaer SK; Hogdall E; DiCioccio RA; McGuire V; Whittemore AS; Gayther SA; Pharoah PD; Webb PM; Chenevix-Trench G; ; ;
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2557-65. PubMed ID: 18086758
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer.
Kyriakopoulou LG; Yousef GM; Scorilas A; Katsaros D; Massobrio M; Fracchioli S; Diamandis EP
Clin Biochem; 2003 Mar; 36(2):135-43. PubMed ID: 12633763
[TBL] [Abstract][Full Text] [Related]
16. KLK15 is a prognostic marker for progression-free survival in patients with radical prostatectomy.
Rabien A; Fritzsche FR; Jung M; Tölle A; Diamandis EP; Miller K; Jung K; Kristiansen G; Stephan C
Int J Cancer; 2010 Nov; 127(10):2386-94. PubMed ID: 20473923
[TBL] [Abstract][Full Text] [Related]
17. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
18. Biochemical characterization of human tissue kallikrein 15 and examination of its potential role in cancer.
Filippou PS; Ren AH; Bala S; Papaioannou MD; Brinc D; Prassas I; Karakosta T; Diamandis EP
Clin Biochem; 2018 Aug; 58():108-115. PubMed ID: 29928903
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of kallikrein 15 gene expression in prostate tissue.
Stephan C; Yousef GM; Scorilas A; Jung K; Jung M; Kristiansen G; Hauptmann S; Bharaj BS; Nakamura T; Loening SA; Diamandis E
J Urol; 2003 Jan; 169(1):361-4. PubMed ID: 12478190
[TBL] [Abstract][Full Text] [Related]
20. Dietary folate and related micronutrients, folate-metabolising genes, and ovarian cancer survival.
Dixon SC; Ibiebele TI; Protani MM; Beesley J; deFazio A; Crandon AJ; Gard GB; Rome RM; Webb PM; Nagle CM;
Gynecol Oncol; 2014 Mar; 132(3):566-72. PubMed ID: 24368279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
